Renaissance Technologies LLC lowered its position in shares of ProAssurance Co. (NYSE:PRA - Free Report) by 3.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 624,800 shares of the insurance provider's stock after selling 24,200 shares during the period. Renaissance Technologies LLC owned 1.22% of ProAssurance worth $9,941,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also bought and sold shares of the company. KBC Group NV increased its holdings in shares of ProAssurance by 75.4% in the fourth quarter. KBC Group NV now owns 4,184 shares of the insurance provider's stock worth $67,000 after purchasing an additional 1,798 shares during the period. KLP Kapitalforvaltning AS purchased a new position in ProAssurance during the fourth quarter worth about $150,000. FMR LLC increased its stake in ProAssurance by 197.8% in the 3rd quarter. FMR LLC now owns 12,063 shares of the insurance provider's stock worth $181,000 after acquiring an additional 8,012 shares during the last quarter. Cornercap Investment Counsel Inc. purchased a new stake in shares of ProAssurance in the 4th quarter valued at about $204,000. Finally, Envestnet Asset Management Inc. bought a new stake in shares of ProAssurance during the 4th quarter valued at about $228,000. Institutional investors own 85.58% of the company's stock.
ProAssurance Trading Up 0.6 %
Shares of ProAssurance stock traded up $0.14 during trading on Tuesday, reaching $23.02. The company's stock had a trading volume of 602,556 shares, compared to its average volume of 417,068. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 0.35. ProAssurance Co. has a 52-week low of $10.76 and a 52-week high of $23.70. The firm's 50-day moving average is $19.37 and its two-hundred day moving average is $16.95. The company has a market cap of $1.18 billion, a price-to-earnings ratio of 27.73 and a beta of -0.09.
ProAssurance (NYSE:PRA - Get Free Report) last posted its quarterly earnings results on Monday, February 24th. The insurance provider reported $0.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.19. The business had revenue of $287.52 million during the quarter, compared to analyst estimates of $274.56 million. ProAssurance had a net margin of 3.71% and a return on equity of 2.65%. On average, sell-side analysts anticipate that ProAssurance Co. will post 0.8 earnings per share for the current year.
Wall Street Analysts Forecast Growth
Several research analysts recently weighed in on the stock. Raymond James cut shares of ProAssurance from a "market perform" rating to an "underperform" rating in a research report on Thursday, April 10th. Citizens Jmp cut shares of ProAssurance from an "outperform" rating to a "market perform" rating in a research report on Thursday, April 3rd. Citigroup lowered shares of ProAssurance to a "market perform" rating in a research report on Thursday, April 3rd. Finally, StockNews.com initiated coverage on ProAssurance in a research note on Thursday, April 17th. They issued a "hold" rating on the stock. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and one has assigned a buy rating to the company's stock. According to MarketBeat.com, ProAssurance presently has an average rating of "Hold" and a consensus target price of $18.67.
View Our Latest Stock Analysis on PRA
ProAssurance Company Profile
(
Free Report)
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.
Further Reading
Before you consider ProAssurance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ProAssurance wasn't on the list.
While ProAssurance currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
